 Home > Active Ingredient News > Antitumor Therapy > Lung cancer: Real-world study of nivolumab for NSCLC that has failed previous treatments

Lung cancer: Real-world study of nivolumab for NSCLC that has failed previous treatments

 Last Update: 2021-09-18
 Source: Internet
 Author: User

Tags

sour thing world

localized cancer

space real

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

What is the overall survival rate of patients with advanced non-small cell lung cancer ( NSCLC ) who have failed previous treatment after receiving nivolumab treatment in the real world? A study published the results and found that the results of the real-world study were similar to those of the Phase III clinical trial.

NSCLC

Metastatic NSCLC progresses during or after platinum-containing chemotherapy, and immune checkpoint inhibitors have become standard treatments

immunity

The results showed that a total of 2585 patients were included, and 1235 (47.

The 1-year and 2-year overall survival rates of the total population were 49% and 28%, respectively

Original source:

Debieuvre D, Juergens RA, Asselain B, Audigier-Valette C, Auliac JB, Barlesi F, Benoit N, Bombaron P, Butts CA, Dixmier A, Gröschel A, Gutz S, Labbé C, Moro-Sibilot D, Pérol M, Raspaud C, Schumann C, Juarez-Garcia A, Lakhdari K, Pettersson F, Penrod JR, Reynaud D, Waldenberger D, Allan V, Sebastian M.
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A Analysis of the pooled-World Real patients from France, Germany, and Canada.
Lung Cancer Jul-2021; 157:.
.
40-47 DOI: 10.
1016 / j.
lungcan.
2021.
04.
022

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.